Moritz Zaiss1, Kai Herz1, Anagha Deshmane1, Mina Kim2, Xavier Golay2, Tobias Lindig3, Benjamin Bender3, Ulrike Ernemann3, and Klaus Scheffler1
1High-field magnetic resonance center, Max Planck Institute for biological cybernetics, Tübingen, Germany, 2University College London, London, United Kingdom, 3Diagnostic & Interventional Neuroradiology, University Clinic Tuebingen, Tübingen, Germany
Synopsis
Dynamic glucose enhanced imaging yields expected CEST effects that are rather small in tissue especially at clinical field
strengths (<2 %). Small movements during the dynamic CEST measurement
together with a subtraction-based evaluation can lead to pseudo CEST effects of
the same order of magnitude. We studied these effects by virtual difference images of a basline scan that were altered by the rigid body
transformations and B0 shifts. Minor motion (0.6 mm translations) and B0
artifacts (7 Hz shift) can lead to pseudo effects in the order of 1% in dynamic
CEST imaging, despite no glucose was injected at all.
INTRODUCTION
Dynamic CEST studies such as dynamic glucose
enhanced imaging, have gained a lot of attention recently, as it monitors the
uptake and wash‐out of glucose shown in tumor models in animals (1,2) and patients with glioblastoma (3,4). The expected CEST effects after injection are rather
small in tissue especially at clinical field strengths (1-2 %). Small
movements during the dynamic CEST measurement together with a subtraction-based
evaluation can lead to pseudo CEST effects of the same order of magnitude.
These artifacts are studied herein.Methods
A 3D snapshot-CEST acquisition (5) optimized for 3T consisted of a pre-saturation module
of 5 s followed by a readout module of duration TRO = 3.5 s.
(FOV=220x180x48 mm3, 1.7x1.7x3mm3, TE=2 ms, TR=5 ms,
BW=400 Hz/pixel, 18 slices, FA=6° and elongation factor E=0.5 (rectangular
spiral reordered)). The CEST saturation period consists of 1 Gaussian-shaped RF
pulse, using a pulse duration of tpulse = 100 ms, and mean B1
= 3 µT. A separate WASABI measurement was acquired for B0 and
B1 mapping (6). A brain tumor patient 3D-CEST baseline scan without
glucose injection performed at 3T was used to generate a virtual dynamic
measurement introducing different kinds of simulated motion and B0
shifts. All subject measurements were performed after informed written consent
and fulfilling all institute policies.Results
Different tissue
generate different Z-spectra, thus different dB0 dependence (Fig
1a). Tumor tissue shows already contrast in the baseline scans (Fig 1bc). Virtual
difference images after the rigid body transformations were calculated (Figure
2) for translations only, rotations only and B0 shifts only. Typical
motion artifacts visible as bright-dark patterns are observed in healthy and
tumorous tissue. In a worst case
scenario such minor motion (0.6 mm translations) and B0 artifacts (7
Hz shift) can lead to pseudo effects in the order of 1% in dynamic CEST imaging
(Figure 3), despite no glucose was injected at all. A real motion applied to
the baseline tumor data shows similar effect sizes (Fig 4). In Figure 4 ROI
evaluations were performed showing the Zdiff contrast with and
without motion correction, and with and without B0 correction. This
analysis reveals that motion is the dominant influence, yet, motion induced B0
changes can still alter the effect strength by about 0.5% and a combined motion
and B0 correction should yield the best results. The pseudo CEST
effects are shown as maps in figure 5 and highlight heterogeneously the tumor
area.Discussion
Especially around tissue interfaces such as CSF
borders or tumor affected areas, the pseudo CEST effect patterns are
non-intuitive and can be mistaken as dynamic agent uptake. Mitigation and
correction strategies are very important for reliable and robust dynamic
glucose enhanced imaging. When motion artifacts are still apparent in data and dynamic
effects are larger than expected glucose uptake the signal remains doubtful.Conclusion
Correction or mitigation even of
small motions is crucial for dynamic CEST imaging, especially in subjects with
lesions. Concomitant B0 alterations can as well induce minor pseudo
effects at 3 T; this influence will be larger at higher magnetic field
strengths. Attempting
dynamic CEST measurements in patients without putting an effort into
sophisticated motion correction is strongly ill-advised, and development of mitigation
and correction strategies strongly encouraged.Acknowledgements
The
financial support of the Max Planck Society, German Research Foundation (DFG,
grant ZA 814/2-1), and European Union’s Horizon 2020 research and innovation
programme (Grant Agreement No. 667510) is gratefully acknowledged.References
(1) Walker-Samuel
et al. Nat Med 2013;19:1067–72.
(2) Xu X, et al Magn Reson Med 2015;74:1556–63.
(3) Xu X, et al Tomography 2015;1:105–114.
(4) Schuenke P et al Scientific Reports 2017;7:42093.
(5) Zaiss et al. NMR Biomed
2018;31:e3879.
(6) Schuenke P et al. Magnetic Resonance in Medicine 2017;77:571–580.